Clinical trials are designed with carefully planned timelines, milestones, and deliverables. Yet, despite meticulous planning, delays remain one of the most common challenges in clinical research.
Every delay
has consequences-not only for sponsors and research teams but, more
importantly, for patients waiting for new therapies.
So, what
causes clinical trials to fall behind schedule?
Here are
some of the most common reasons.
1. Slow
Patient Recruitment
Patient
recruitment continues to be one of the leading causes of delays in clinical
trials. Strict eligibility criteria, limited patient awareness, competition
from other studies, and unrealistic recruitment projections can significantly
extend study timelines.
Best
Practice: Develop patient-centric recruitment strategies,
conduct robust feasibility assessments, and select sites with proven
recruitment capabilities.
2. Delays
in Site Activation
Before a
clinical site can begin enrolling participants, multiple approvals and
operational activities must be completed, including:
- Ethics Committee/Institutional Review Board
approvals
- Regulatory approvals
- Contract negotiations
- Budget finalisation
- Investigator training
- Site initiation visits
Even minor
delays during start-up can postpone the entire study.
Best
Practice: Begin regulatory and contractual activities early and
maintain proactive communication with all stakeholders.
3. Protocol
Amendments
Changes to
the study protocol after initiation are more common than many realise. While
amendments may improve the study, they often require additional approvals, site
retraining, updated documentation, and participant re-consenting.
Each
amendment can have a significant impact on study timelines and costs.
Best
Practice: Invest time in developing a scientifically robust and
operationally feasible protocol before study initiation.
4. Poor
Data Quality
Incomplete
case report forms, protocol deviations, missing source documentation, and
delayed data entry create additional queries and require extensive data
cleaning before database lock.
Poor-quality
data often results in delays during statistical analysis and regulatory
submission preparation.
Best
Practice: Focus on data quality from the first patient
enrolled—not just at the end of the study.
5. Supply
Chain Challenges
Clinical
trials depend on the timely availability of investigational products,
laboratory kits, medical devices, and study materials.
Manufacturing
delays, customs clearance, temperature excursions, or distribution issues can
interrupt study conduct.
Best
Practice: Build contingency plans into clinical supply
strategies and closely monitor inventory throughout the study.
6.
Ineffective Communication
Clinical
trials involve sponsors, CROs, investigators, laboratories, vendors, regulatory
teams, statisticians, and data managers.
Without
clear communication and defined responsibilities, misunderstandings can quickly
become operational delays.
Best
Practice: Establish regular governance meetings, clear
escalation pathways, and transparent communication channels.
7. Resource
Constraints
Limited
staffing, competing priorities, or insufficient expertise can affect
monitoring, data review, regulatory submissions, and overall project
management.
Best
Practice: Build multidisciplinary teams with the right
expertise and allocate resources proactively.
8.
Regulatory and Compliance Requirements
Health
authorities and ethics committees play a vital role in ensuring participant
safety and study integrity. However, responding to regulatory queries or
fulfilling additional documentation requirements can extend timelines.
Best
Practice: Prepare high-quality submission packages and maintain
regulatory readiness throughout the study lifecycle.
9.
Unexpected Operational Risks
Clinical
research rarely follows a perfectly predictable path. Site staff turnover,
natural disasters, public health emergencies, technology failures, or
vendor-related issues can disrupt study progress.
Best
Practice: Implement comprehensive risk management plans with
predefined mitigation strategies.
10.
Insufficient Project Oversight
Even
well-designed studies can struggle without effective coordination. Monitoring
progress against milestones, identifying risks early, and maintaining alignment
across teams are essential for keeping studies on track.
Best
Practice: Strong project management transforms reactive
problem-solving into proactive decision-making.